Harrow Inc
General ticker "HROW" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.4B
Harrow Inc follows the US Stock Market performance with the rate: 60.4%.
Estimated limits based on current volatility of 2.6%: low 33.57$, high 35.35$
Factors to consider:
- Current price 222.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.32$, 10.53$]
- 2024-12-30 to 2025-12-30 estimated range: [3.46$, 8.22$]
Short-term HROW quotes
Long-term HROW plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $130.19MM |
| Operating Expenses | $129.76MM |
| Operating Income | $0.43MM |
| Non-Operating Income | $-24.37MM |
| Interest Expense | $21.32MM |
| R&D Expense | $6.88MM |
| Income(Loss) | $-23.94MM |
| Taxes | $0.47MM |
| Profit(Loss) | $-24.41MM |
| Stockholders Equity | $70.77MM |
| Inventory | $10.87MM |
| Assets | $312.16MM |
| Operating Cash Flow | $3.84MM |
| Capital expenditure | $152.55MM |
| Investing Cash Flow | $-152.55MM |
| Financing Cash Flow | $126.53MM |
| Earnings Per Share* | $-0.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.